Providing Strategic Medical Guidance in Advancing HyBryte™ Clinical Development PRINCETON, N.J., Oct. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...
Hence then, the article about soligenix updates united states medical advisory board for cutaneous t cell lymphoma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma )
Also on site :
- Dolly Parton’s Stainless Steel Travel Mugs are ‘Perfect’ for ‘Coffee in the Morning,’ and Start at $20 on Amazon
- “We Don’t See This as Entertainment”: ‘THR Presents’ Q&A With Octavia Spencer on True Crime Docu-Series ‘Lost Women of Alaska’
- 'They basically used these dried-up wells just to throw people in': 43 skeletons found in Roman-era well may be evidence of deadly plague